Compartment SyndromeThe InSpectra™ StO2 Tissue Oxygenation Monitor has not been cleared by the FDA for use in diagnosing compartment syndrome. Additional clinical studies are required to establish the value of these measurements in assessing patient status relating to compartment syndrome. Click here to see the complete Indications for Use.
Monitoring For Compartmental Syndrome Using Near-Infrared Spectroscopy: A Non-Invasive, Continuous, Transcutaneous Monitoring TechniqueGarr JL, Gentilello LM, Cole PA, Mock CN, Matsen FA.
J Trauma. 1999; 46:613-618
In acute compartment syndrome of the upper and lower extremity, increased tissue pressure severely compromises blood flow through skeletal muscle, resulting in muscle ischemia. In porcine models of compartment syndrome, StO
2 was shown to correlate strongly with tissue pressure measurements and loss of neuromuscular function.
Near-Infrared Spectroscopy: A Potential Method For Continuous, Transcutaneous Monitoring For Compartmental Syndrome In Critically Injured Patients.Arbabi S, Brundage SI, Gentilello LM
J Trauma. 1999; 47:829-833
In another porcine model of compartment syndrome, hypotension was added to hypoxemia and demonstrated that the
InSpectra™ System could measure compromised tissue oxygenation in the presence of unstable, shock-like physiology.
Utility Of Near-Infrared Spectroscopy In The Diagnosis Of Lower Extremity Compartment Syndrome.Giannotti G, Cohn SM, Brown M, Varela JE, McKenney MG, Wiseberg JA
J Trauma. 2000;48: 396-401
In patients diagnosed with lower extremity compartment syndrome, Giannotti et al identified a statistically significant difference in StO
2 measurements between affected and control limbs.
